MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions
View by Date

Wednesday, June 22, 2016

12:00pm-1:30pm
Acute cerebellar degeneration as the first manifestation of Sjögren syndrome: A case report

R. Maciel, S. Camargos, F. Cardoso (Belo Horizonte, Brazil)

Ataxia  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Affective theory of mind in Parkinson’s disease

A.M. Hammad, S. Ghozy, S.I. El-Jaafary (Cairo, Egypt)

Parkinson's disease: Psychiatric manifestations  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Alterations in muscle synergies in early stage Parkinson’s disease

J.F. Daneault, G. Vergara-Diaz, C. Adans-Dester, G. Ferreira-Carvalho, V.C.K. Cheung, P. Bonato (Charlestown, MA, USA)

Parkinson's disease: Neuroimaging and neurophysiology  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Altered brain activation in complex walking conditions in patients with Parkinson’s disease

I. Maidan, K. Rosenberg-Katz, Y. Jacob, N. Giladi, J.E. Deutsch, A. Mirelman, J.M. Hausdorff (Tel Aviv, Israel)

Parkinson's disease: Neuroimaging and neurophysiology  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Altered cerebello-thalamo-cortical pathway in Huntington’s disease

J.F. Martín-Rodríguez, M. Gómez-Crespo, M.T. Cáceres-Redondo, L. Vargas-González, F.J. Palomar, P. Porcacchia, P. Álvarez de Toledo, J.M. Oropesa-Ruiz, F. Carrillo, I. Huertas-Fernández, S. Jesús, P. Mir (Seville, Spain)

Huntington's disease  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Altered resting-state functional interhemispheric connectivity in Parkinson’s disease

X. Dan, S. Lin, A. Liu, Z. Wang, M.J. McKeown, P. Chan (Beijing, People's Republic of China)

Parkinson's disease: Neuroimaging and neurophysiology  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Alternatives for reducing chorea in Huntington disease, a long-term trial (ARC-HD): Updated week 8 results for the switch cohort

V. Sung, D. Stamler, D.O. Claassen (Birmingham, AL, USA)

Huntington's disease  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Ambulatory assessment of tremor

M. Horne, S. O'Connor, P. Churchward, T. Perera, M. Braybrook (Parkville, Australia)

Phenomenology and clinical assessment of movement disorders  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Analysis of cognitive disorders of Parkinson’s disease (PD) in the comparative aspect

S. Lukmonov, D. Tolibov, A. Sobirov, F. Yunusov, D. Jalilov, K. Abdukhalimova, A. Kalendarev (Tashkent, Uzbekistan)

Cognitive disorders  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Analysis of factors associated with cognitive and functional performance in Parkinsonian with normal mini-mental state examination

R. Breder, M.A.A. Leite, M.C.A. Ribas, M. Orsini (Niterói, Brazil)

Parkinson's disease: Cognition  ·  Exhibit Hall located in Hall B, Level 2
  • «Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 54
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley